Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Completed · Not applicable

Conditions studied: Bacteremia, Fungemia, Bloodstream Infection

In brief

Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?

Key facts

Study ID

NCT01898208

Run by

Mayo Clinic

People needed

743

Starts

2013-08-01

Expected to finish

2014-08-01

Last updated by the study team

2016-03-15

Who can join

Age: any, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Positive blood culture during the study period.
• No positive blood cultures in prior 7 days
• Minnesota state research authorization provided

You may not qualify if…

• No Minnesota state research authorization
• Deceased or transitioned to comfort care within 24 hours of enrollment
• Positive blood culture in prior 7 days
• Previously enrolled in this study
• Negative Gram stain

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.